← Leaderboards
Sharon Cresci
Washington University
$7,282,232
Attributed
$7,400,185
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $777.5K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,400,185 · 4
By mechanism
R01$6,746,278 · 2
R21$653,907 · 2
Top collaborators
- Linda Ruth Peterson2 shared
Most similar at Washington University
Same institution · by research overlap
- Timothy J Eberlein$71,591,509
- Edwin N Trevathan$6,019,845
- Anne Justice$4,629,671
- Ginger E Nicol$3,499,533
- Gabriel Alejandro De Erausquin$22,131,859
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortVariantGeneticCoronary ArteriosclerosisGenesEventCardiovascular SystemUnited StatesMyocardial InfarctionQuality Of LifeHealth StatusGenotypeGenetic VariantAdultMortalityMedicalBaseSymptomsDesignGenomicsDiabetes MellitusPatient CarePathway InteractionsResearch Personnel
Grant awards (15)
Determining Potential Mechanisms of Worse Outcomes in Black HCM Patients$742,028
R01 · FY2025 · HL · contact PI
Determining Potential Mechanisms of Worse Outcomes in Black HCM Patients$740,940
R01 · FY2024 · HL · contact PI
Determining Potential Mechanisms of Worse Outcomes in Black HCM Patients$777,498
R01 · FY2023 · HL · contact PI
PREDICTION OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): A NEW PLASMA BIOMARKER$118,125
R21 · FY2020 · HL
Genomic variants associated with angina and health status outcome after MI$615,747
R01 · FY2019 · NR · contact PI
PREDICTION OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): A NEW PLASMA BIOMARKER$117,782
R21 · FY2019 · HL
Genomic variants associated with angina and health status outcome after MI$621,384
R01 · FY2018 · NR · contact PI
Genomic variants associated with angina and health status outcome after MI$626,478
R01 · FY2017 · NR · contact PI
Genomic variants associated with angina and health status outcome after MI$642,704
R01 · FY2016 · NR · contact PI
Genomic variants associated with angina and health status outcome after MI$652,493
R01 · FY2015 · NR · contact PI
Genomic variants associated with angina and health status outcome after MI$407,672
R01 · FY2013 · NR · contact PI
Genomic variants associated with angina and health status outcome after MI$449,631
R01 · FY2012 · NR · contact PI
Genomic variants associated with angina and health status outcome after MI$469,703
R01 · FY2011 · NR · contact PI
Association of PPAR-pathway gene polymorphisms with diabetic outcomes in BARI 2D$114,000
R21 · FY2008 · HL · contact PI
Association of PPAR-pathway gene polymorphisms with diabetic outcomes in BARI 2D$304,000
R21 · FY2007 · HL · contact PI